Strides Pharma Science secures FDA approval for Gabapentin tablets
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. ... Read More
Venus Remedies receives significant boost with PLI Scheme disbursement
Venus Remedies Ltd, a leading player in India's generic drug manufacturing sector, has recently been awarded a pivotal disbursement of Rs 7.5 crore under the ... Read More
Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply
Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations, has announced a ... Read More
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Nordic Capital proposes $846m acquisition of Advanz Pharma
In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz Pharma, a UK-based specialty pharmaceutical company, for ... Read More
Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients
Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase 2 clinical trial. The trial aims to ... Read More
Blackstone seals deal to acquire AYUMI Pharmaceutical: A strategic move in Japan’s pharma market
Global investment firm Blackstone has announced the acquisition of AYUMI Pharmaceutical, a leading Japanese specialty pharma company, marking its first controlling private equity investment in ... Read More
Aurobindo Pharma to acquire Sandoz US dermatology and oral solids divisions for $1bn
Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division of the Swiss pharmaceutical giant Novartis. The ... Read More
Avara Pharmaceutical expands into Canadian market with acquisition of sterile manufacturing facility
Avara Pharmaceutical Services, a prominent US-based contract development and manufacturing organization (CDMO), has successfully completed the acquisition of a sterile manufacturing facility for injectable medicines ... Read More
Olon acquires API manufacturing plant in Maharashtra, India to expand global footprint
Olon, a prominent developer and manufacturer of active pharmaceutical ingredients (API) based in Italy, has strategically expanded its global operations with the acquisition of a ... Read More